STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS

解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究

基本信息

项目摘要

Two proteins, barnase, the extracellular ribonuclease of Bacillus amyloliquefaciens, and barstar, its intracellular inhibitor, are used as a model system for the study of protein folding and protein-protein interactions. Barnase is one of an homologous group of ribonuclease occurring in both prokaryotes and eukaryotes. Recombinant DNA techniques are being applied with three major aims: (1) to facilitate production of wild type and mutant proteins; (2) to examine the structural and control sequences of the genes; and (3) to make specific changes in the sequences to test theories of folding and probe the barnase- barstar interaction. The lethal effect of the cloned wild type barnase gene can be repressed by expression of the barstar gene on the same plasmid. E. coli plasmid vectors have been devised for both proteins and both can now be obtained essentially pure in 100 mg quantities. DNA and amino acid sequences and x- ray structures of both are known as well as the NMR solution structure of barnase. A synthetic fluorescent substrate has been used to study hydrolysis kinetics and to look at the kinetics and stability of the barnase-barstar interaction for native and mutant proteins. Close to a hundred directed mutations in each protein have been produced. Some of these were aimed at specific questions but most are part of a survey of the protein surfaces designed to locate their areas of interaction and residues on both have been identified as being so involved. The two Cys residues of barstar can both be replaced by Ala without loss of activity (in vitro or in vivo, but with some reduction in the strength of the bond) or yield will greatly simplify future studies of barstar folding. Such replacement of either or both of the Cys residues reduces the stability of barstar only to that of the wild-type measured in the presence of mercaptoethanol or DTT. Several methods have been developed for measuring the relative and absolute strength of the bond between barnase and barstar for various combinations of wild-type and mutant proteins. For the wild-type proteins the dissociation coefficient is on the order of 10 to the -13. Recent work, elsewhere, in which the barnase gene was attached to a eukaryotic promoter in order to kill the tissue in which that promoter is expressed (in the first instance to produce male sterility in plants) has aroused considerable interest in its possible use in developmental studies and is the key to a variety of anti-viral strategies.
两种蛋白质,藤蔓酶,芽孢杆菌胞外核糖核酸酶

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

R W HARTLEY其他文献

R W HARTLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('R W HARTLEY', 18)}}的其他基金

STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    5201904
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌的核糖核酸酶及其抑制剂
  • 批准号:
    3875541
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    6161886
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
解淀粉芽孢杆菌的核糖核酸及其抑制剂
  • 批准号:
    3940232
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
解淀粉芽孢杆菌的核糖核酸及其抑制剂
  • 批准号:
    4689017
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    2572771
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
解淀粉芽孢杆菌的核糖核酸及其抑制剂
  • 批准号:
    3917361
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUENFACIENS
解淀粉芽孢杆菌的核糖核酸及其抑制剂
  • 批准号:
    3964011
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    3753948
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
STUDY OF A RIBONUCLEASE AND ITS INHIBITOR FROM BACILLUS AMYLOLIQUEFACIENS
解淀粉芽孢杆菌核糖核酸酶及其抑制剂的研究
  • 批准号:
    3776059
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 批准年份:
    2023
  • 资助金额:
    46 万元
  • 项目类别:
    面上项目
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 批准年份:
    2018
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
  • 批准号:
    31571933
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
  • 批准号:
    31371861
  • 批准年份:
    2013
  • 资助金额:
    15.0 万元
  • 项目类别:
    面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
  • 批准号:
    31371845
  • 批准年份:
    2013
  • 资助金额:
    15.0 万元
  • 项目类别:
    面上项目
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
  • 批准号:
    31171774
  • 批准年份:
    2011
  • 资助金额:
    66.0 万元
  • 项目类别:
    面上项目

相似海外基金

Knowledgebase of Escherichia coli Genome and Metabolism
大肠杆菌基因组和代谢知识库
  • 批准号:
    10716050
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Copper Sensing in Uropathogenic Escherichia coli
尿路致病性大肠杆菌中的铜感应
  • 批准号:
    10604449
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
  • 批准号:
    10747651
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Inactivation of Escherichia coli using high hydrostatic pressure from viewpoints of cell shrinkage and expansion
从细胞收缩和扩张的角度利用高静水压灭活大肠杆菌
  • 批准号:
    23K05105
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Metabolic engineering of Escherichia coli for carbon capture and hydrogen storage.
用于碳捕获和氢储存的大肠杆菌代谢工程。
  • 批准号:
    2869802
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
Development of new removal method targeting Escherichia coli causing colorectal cancer
开发针对引起结直肠癌的大肠杆菌的新去除方法
  • 批准号:
    23K19489
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Structural Determinants of Permeation Barriers in Escherichia coli
大肠杆菌渗透屏障的结构决定因素
  • 批准号:
    10749251
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
  • 批准号:
    10741541
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A novel genetic switch with an optimal ON/OFF ratio to preserve growth performance prior to Escherichia coli autolysis for enhanced plasmid release
一种具有最佳开/关比的新型基因开关,可在大肠杆菌自溶之前保持生长性能,从而增强质粒释放
  • 批准号:
    2881246
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR ANTIMICROBIAL RESISTANCE ESCHERICHIA COLI
大肠杆菌耐药性体外诊断的开发
  • 批准号:
    10912990
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了